Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook

Go back to Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook

Inspire Medical Systems (INSP) PT Lowered to $220 at Morgan Stanley

February 11, 2025 7:09 AM EST

Morgan Stanley analyst Kallum Titchmarsh lowered the price target on Inspire Medical Systems (NYSE: INSP) to $220.00 (from $230.00) while maintaining a Overweight rating.

The analyst comments "A good way for INSP to close out the year with profitability coming in comfortably ahead. Both existing... More

Inspire Medical Systems (INSP) PT Raised to $194 at Leerink Partners

February 11, 2025 6:32 AM EST

Leerink Partners analyst Mike Kratky raised the price target on Inspire Medical Systems (NYSE: INSP) to $194.00 (from $193.00) while maintaining a Market Perform rating.

The analyst comments "Bottom Line: We are bumping up our price target on INSP to $194 (from $193) to reflect our updated model and slightly lower share count following the company's 4Q24 earnings. However, we are... More